loadpatents
name:-0.023952960968018
name:-0.023512125015259
name:-0.0079469680786133
Laudon; Moshe Patent Filings

Laudon; Moshe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Laudon; Moshe.The latest application filed is for "melatonin mini-tablets and method of manufacturing the same".

Company Profile
7.26.22
  • Laudon; Moshe - Tel Aviv IL
  • LAUDON; Moshe - Kfar Saba IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Melatonin mini-tablets and method of manufacturing the same
Grant 10,869,857 - Laudon , et al. December 22, 2
2020-12-22
Melatonin mini-tablets and method of manufacturing the same
Grant 10,849,856 - Laudon , et al. December 1, 2
2020-12-01
Melatonin Mini-tablets And Method Of Manufacturing The Same
App 20200306193 - LAUDON; Moshe ;   et al.
2020-10-01
Melatonin Mini-tablets And Method Of Manufacturing The Same
App 20200306227 - LAUDON; Moshe ;   et al.
2020-10-01
Melatonin mini-tablets and method of manufacturing the same
Grant 10,722,494 - Laudon , et al.
2020-07-28
Method For Treating Pruritus And/or Itch
App 20190175554 - LAUDON; Moshe
2019-06-13
Melatonin Mini-tablets And Method Of Manufacturing The Same
App 20190060277 - LAUDON; Moshe ;   et al.
2019-02-28
CD44 splice variants in neurodegenerative diseases
Grant 9,416,166 - Pinner , et al. August 16, 2
2016-08-16
Cd44 Splice Variants In Neurodegenerative Diseases
App 20150266940 - Pinner; Elhanan ;   et al.
2015-09-24
Method and composition for enhancing cognition in alzheimer's patients
Grant 9,119,846 - Zisapel , et al. September 1, 2
2015-09-01
Methods for treating neurological disease
Grant 9,101,613 - Laudon , et al. August 11, 2
2015-08-11
CD44 splice variants in neurodegenerative diseases
Grant 9,018,180 - Pinner , et al. April 28, 2
2015-04-28
Method And Composition For Enhancing Cognition In Alzheimer's Patients
App 20140377351 - ZISAPEL; Nava ;   et al.
2014-12-25
Composition For Improving Cognition And Memory
App 20140378512 - ZISAPEL; Nava ;   et al.
2014-12-25
Composition for improving cognition and memory
Grant 8,859,593 - Zisapel , et al. October 14, 2
2014-10-14
Method of treatment comprising administering controlled release melatonin
Grant 8,728,511 - Zisapel , et al. May 20, 2
2014-05-20
Methods For Treating Neurological Disease
App 20130324583 - Laudon; Moshe ;   et al.
2013-12-05
Pyrone-indole derivatives and process for their preparation
Grant 8,569,355 - Laudon , et al. October 29, 2
2013-10-29
Novel Pyrone-indole Derivatives And Process For Their Preparation
App 20120302620 - Laudon; Moshe ;   et al.
2012-11-29
2-aminobenzoyl derivatives
Grant 8,309,767 - Zisapel , et al. November 13, 2
2012-11-13
Pyrone-indole derivatives and process for their preparation
Grant 8,242,163 - Laudon , et al. August 14, 2
2012-08-14
Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
Grant 8,236,858 - Peleg-Shulman , et al. August 7, 2
2012-08-07
Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
App 20120070501 - Zisapel; Nava ;   et al.
2012-03-22
Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents
App 20110319494 - Peleg-Shulman; Tal ;   et al.
2011-12-29
Method and formulation for treating resistance to antihypertensives and related conditions
Grant 8,075,914 - Zisapel , et al. December 13, 2
2011-12-13
Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
Grant 8,003,702 - Peleg-Shulman , et al. August 23, 2
2011-08-23
Cd44 Splice Variants In Neurodegenerative Diseases
App 20110172286 - Pinner; Elhanan ;   et al.
2011-07-14
Novel Pyrone-Indole Derivatives and Process for Their Preparation
App 20100048662 - Laudon; Moshe ;   et al.
2010-02-25
Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents
App 20100048663 - Peleg-Shulman; Tal ;   et al.
2010-02-25
Pyrone-indole derivatives and process for their preparation
Grant 7,635,710 - Laudon , et al. December 22, 2
2009-12-22
Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
Grant 7,622,495 - Peleg-Shulman , et al. November 24, 2
2009-11-24
Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents
App 20080132559 - Peleg-Shulman; Tal ;   et al.
2008-06-05
Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
App 20080085317 - Zisapel; Nava ;   et al.
2008-04-10
Indole derivatives
Grant 7,355,054 - Zisapel , et al. April 8, 2
2008-04-08
Method and formulation for treating resistance to antihypertensives and related conditions
Grant 7,332,177 - Zisapel , et al. February 19, 2
2008-02-19
Novel pyrone-indole derivatives and process for their preparation
App 20080027121 - Laudon; Moshe ;   et al.
2008-01-31
2-Aminobenzoyl derivatives
App 20060270733 - Zisapel; Nava ;   et al.
2006-11-30
Composition for improving cognition and memory
App 20060229340 - Zisapel; Nava ;   et al.
2006-10-12
Indole derivatives
App 20050159463 - Zisapel, Nava ;   et al.
2005-07-21
Indole derivatives
Grant 6,858,642 - Zisapel , et al. February 22, 2
2005-02-22
Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
App 20050020664 - Zisapel, Nava ;   et al.
2005-01-27
Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them
Grant 6,780,884 - Zisapel , et al. August 24, 2
2004-08-24
Derivating of tryptamine and analogous componds and pharmaceutical formulations containing them
App 20040029950 - Zisapel, Nava ;   et al.
2004-02-12
Melatonin antagonist
Grant 4,880,826 - Zisapel , et al. November 14, 1
1989-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed